AXOVANT GENE THERAPIES LTD's ticker is AXGT and the CUSIP is G0750W203. A total of 40 filers reported holding AXOVANT GENE THERAPIES LTD in Q2 2019. The put-call ratio across all filers is 0.99 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $559,000 | +270.2% | 120,925 | +126.5% | 0.09% | +10.7% |
| Q2 2020 | $151,000 | +51.0% | 53,384 | +30.1% | 0.08% | +236.0% |
| Q1 2020 | $100,000 | -51.7% | 41,037 | +1.7% | 0.02% | +4.2% |
| Q4 2019 | $207,000 | +149.4% | 40,343 | +213.7% | 0.02% | +118.2% |
| Q3 2019 | $83,000 | -47.8% | 12,861 | -49.7% | 0.01% | -38.9% |
| Q2 2019 | $159,000 | – | 25,561 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|